Rajesh Sachdeo

Summary

Publications

  1. ncbi Effects of oxcarbazepine on sodium concentration and water handling
    Rajesh C Sachdeo
    New Jersey Comprehensive Epilepsy Center, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ 08901, USA
    Ann Neurol 51:613-20. 2002
  2. ncbi Improved quality of life in patients with partial seizures after conversion to oxcarbazepine monotherapy
    Rajesh C Sachdeo
    Princeton Medical Center, Princeton, NJ 08540, USA
    Epilepsy Behav 9:457-63. 2006
  3. ncbi Monotherapy clinical trial design
    Rajesh Sachdeo
    Epilepsy Program, Jersey Shore Medical Center, Neptune, New Jersey 07754, USA
    Neurology 69:S23-7. 2007
  4. ncbi Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society
    Jacqueline A French
    Neurological Institute, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Epilepsia 45:410-23. 2004
  5. ncbi Sustained efficacy and long-term safety of oxcarbazepine: one-year open-label extension of a study in refractory partial epilepsy
    Ahmad Beydoun
    Department of Neurology, University of Michigan Health System, Ann Arbor, Michigan 48109 0036, USA
    Epilepsia 44:1160-5. 2003
  6. ncbi Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society
    Jacqueline A French
    Neurological Institute, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Epilepsia 45:401-9. 2004

Detail Information

Publications6

  1. ncbi Effects of oxcarbazepine on sodium concentration and water handling
    Rajesh C Sachdeo
    New Jersey Comprehensive Epilepsy Center, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ 08901, USA
    Ann Neurol 51:613-20. 2002
    ..Possible mechanisms include a direct effect of oxcarbazepine on the renal collecting tubules or an enhancement of their responsiveness to circulating antidiuretic hormone...
  2. ncbi Improved quality of life in patients with partial seizures after conversion to oxcarbazepine monotherapy
    Rajesh C Sachdeo
    Princeton Medical Center, Princeton, NJ 08540, USA
    Epilepsy Behav 9:457-63. 2006
    ..Quality of life (QOL) was assessed in patients who switched to oxcarbazepine monotherapy because of the lack of efficacy or poor tolerability of their current antiepileptic drug (AED)...
  3. ncbi Monotherapy clinical trial design
    Rajesh Sachdeo
    Epilepsy Program, Jersey Shore Medical Center, Neptune, New Jersey 07754, USA
    Neurology 69:S23-7. 2007
    ..It is hoped that use of appropriately designed monotherapy clinical trials will help to identify a new generation of AEDs in the future for monotherapy in epilepsy patients...
  4. ncbi Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society
    Jacqueline A French
    Neurological Institute, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Epilepsia 45:410-23. 2004
    ....
  5. ncbi Sustained efficacy and long-term safety of oxcarbazepine: one-year open-label extension of a study in refractory partial epilepsy
    Ahmad Beydoun
    Department of Neurology, University of Michigan Health System, Ann Arbor, Michigan 48109 0036, USA
    Epilepsia 44:1160-5. 2003
    ..To evaluate the long-term efficacy, tolerability, and safety of oxcarbazepine (OXC) in medically refractory partial epilepsy...
  6. ncbi Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society
    Jacqueline A French
    Neurological Institute, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Epilepsia 45:401-9. 2004
    ..S. Food and Drug Administration] in the treatment of children and adults with newly diagnosed partial and generalized epilepsies...